Create Free Account

By creating account you will get access to hot stocks & personalised emails

Vitura Health Limited

Healthcare AU VIT

0.095AUD
-0.003(3.06%)

Last update at 2024-11-13T04:41:00Z

Day Range

0.100.10
LowHigh

52 Week Range

0.070.35
LowHigh

Fundamentals

  • Previous Close 0.10
  • Market Cap54.71M
  • Volume614864
  • P/E Ratio9.50
  • Dividend Yield-%
  • EBITDA5.28M
  • Revenue TTM123.87M
  • Revenue Per Share TTM0.22
  • Gross Profit TTM 40.54M
  • Diluted EPS TTM0.01

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax 20.05M 9.74M -4.20585M -3.98968M -2.95824M
Minority interest 0.06M 0.04M 0.16M 0.05M -
Net income 13.81M 6.05M -4.04921M -3.93721M -2.91430M
Selling general administrative 14.37M 14.13M 4.21M 3.85M 0.81M
Selling and marketing expenses 0.54M 0.53M 0.29M 0.07M 2.05M
Gross profit 25.96M 25.43M 0.87M 0.12M -0.02742M
Reconciled depreciation 0.99M 0.68M 3.43M 0.04M -
Ebit 19.86M 10.19M -3.91169M -3.82555M -2.89095M
Ebitda 20.85M 10.87M -0.48662M -3.78454M -2.86353M
Depreciation and amortization 0.99M 0.68M 3.43M 0.04M 0.03M
Non operating income net other - - - - -
Operating income 19.86M 10.19M -3.91169M -3.82555M -2.89095M
Other operating expenses 97.48M 57.75M 9.16M 4.25M 2.89M
Interest expense 0.03M 0.44M 0.29M 0.21M 0.13M
Tax provision 6.30M 3.73M 0.47M 0.00000M -
Interest income 0.33M 0.00907M 0.05M 0.13M -
Net interest income 0.11M -0.43237M -0.24760M -0.07294M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 6.30M 3.73M 0.22M 0.32M -0.04394M
Total revenue 117.34M 66.99M 1.69M 0.12M -
Total operating expenses 6.09M 16.19M 8.34M 4.24M 2.86M
Cost of revenue 91.39M 41.56M 0.82M 0.00706M 0.03M
Total other income expense net 0.19M 0.25M 0.08M 0.21M -0.06729M
Discontinued operations - - - - -
Net income from continuing ops 13.75M 6.01M -4.20585M -3.98968M -
Net income applicable to common shares 13.81M 6.05M 1.42M -3.93721M -
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 71.28M 46.90M 42.87M 12.69M 16.23M
Intangible assets - 7.10M 0.33M 0.20M 0.20M
Earning assets - - - - -
Other current assets 0.88M 0.19M 0.04M 0.47M 0.16M
Total liab 32.84M 11.92M 16.79M 3.47M 2.73M
Total stockholder equity 38.78M 34.98M 26.10M 9.30M 13.44M
Deferred long term liab - - - - -
Other current liab 10.60M 0.84M 5.81M 0.61M 0.43M
Common stock 30.79M 24.04M 22.78M 20.01M 20.01M
Capital stock - 24.04M 22.78M 20.01M 20.01M
Retained earnings 12.67M 14.74M 6.47M -10.83327M -6.78406M
Other liab - 0.08M 0.05M 0.01M -
Good will 18.52M 6.83M 6.83M 0.29M 0.29M
Other assets - 1.38M 2.54M 0.21M -
Cash 11.35M 18.85M 16.08M 9.47M 14.69M
Cash and equivalents - - - - -
Total current liabilities 23.36M 10.87M 12.17M 3.21M 0.63M
Current deferred revenue 0.00722M - - - -
Net debt -0.32607M - -11.01744M -7.10327M -12.47835M
Short term debt 1.73M 0.00000M 0.49M 2.11M 0.10M
Short long term debt - - - 2.01M 0.03M
Short long term debt total 11.02M - 5.06M 2.36M 2.21M
Other stockholder equity - -3.80305M -3.14862M -0.14082M 0.21M
Property plant equipment - 2.41M 5.58M 0.91M 0.49M
Total current assets 30.97M 36.00M 27.59M 11.76M 15.25M
Long term investments - 0.37M 0.60M - -
Net tangible assets - 27.88M 18.94M 3.81M 12.95M
Short term investments - - - - -
Net receivables 13.74M 9.34M 5.76M 0.43M 0.03M
Long term debt - - - - 2.10M
Inventory 5.01M 6.91M 5.03M 1.34M 0.19M
Accounts payable 11.03M 6.92M 5.87M 0.50M 0.10M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -4.67807M - -3.14862M 0.12M 0.21M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.77M - - - -
Deferred long term asset charges - - - - -
Non current assets total 40.31M 10.89M 15.28M 0.93M 0.98M
Capital lease obligations - 1.28M 5.06M 0.35M 0.39M
Long term debt total - 1.04M 4.57M 0.54M 2.10M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -0.83772M 2.00M -0.16068M -0.51592M -
Change to liabilities 0.29M 6.19M 2.62M -0.98242M -
Total cashflows from investing activities -0.83772M 2.00M -0.47936M -0.51592M -
Net borrowings -0.63558M -0.31811M -0.37965M -0.58441M -
Total cash from financing activities -6.09859M -1.50365M -0.26203M 19.93M 1.69M
Change to operating activities 0.06M -0.21022M -0.02075M -0.05650M -
Net income 13.81M 6.05M 1.42M -3.93721M -2.91430M
Change in cash 2.77M 14.00M -5.21877M 14.53M 0.10M
Begin period cash flow 16.08M 2.08M 14.69M 0.16M 0.06M
End period cash flow 18.85M 16.08M 9.47M 14.69M 0.16M
Total cash from operating activities 9.71M 13.50M 1.07M -4.88980M -1.65774M
Issuance of capital stock - - - 23.60M -
Depreciation 0.99M 0.68M 0.21M 0.04M 0.03M
Other cashflows from investing activities 0.08M 2.37M -0.22000M -0.09982M -
Dividends paid -5.46301M 1.50M 0.34M 19.92M -
Change to inventory -1.87892M -1.92881M -1.86456M -0.19245M -
Change to account receivables -3.57603M -3.57964M -1.76879M 0.00776M 0.04M
Sale purchase of stock - -1.18554M -0.17189M -3.09282M -
Other cashflows from financing activities -0.63558M 2.69M -0.05732M 19.92M 1.69M
Change to netincome 0.01M 6.30M 0.48M 0.24M -
Capital expenditures 0.93M 0.38M 0.06M 0.27M 0.00718M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -5.10282M 0.47M -1.03111M -1.23483M 1.17M
Stock based compensation 0.75M 2.53M 0.03M 0.21M -
Other non cash items 7.15M 6.99M 1.90M 1.50M 0.06M
Free cash flow 8.78M 13.13M 1.01M -5.15921M -1.66492M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
VIT
Vitura Health Limited		 -0.003 3.06% 0.10 9.50 - 0.44 1.46 0.45 7.74
AFP
AFT Pharmaceuticals Ltd		 -0.02 0.78% 2.55 17.71 19.08 1.35 3.31 1.56 10.94
VLS
Vita Life Sciences Ltd		 - -% 2.09 12.06 - 1.46 2.42 1.15 6.64
LV1
Live Verdure Ltd		 0.03 4.29% 0.73 - - 52.75 39.01 42.66 -5.083
PER
Percheron Therapeutics Limited		 -0.003 3.53% 0.08 - - 27.59 8.75 347.00 -4.4641

Reports Covered

Stock Research & News

View All

Profile

Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia. It operates through two segments: Sales and Distribution; and Clinics and Services. The company operates CanView, an online platform that delivers prescribing, dispensing, and medication management solutions for alternative therapies; Doctors on Demand, a premier provider of on-demand virtual healthcare services; BHC, an alternative therapy distributor; CDA Clinics, which provides medicinal consultations and prescription services; and Cannadoc, a medicinal cannabis clinic that offers telehealth consultations. It also offers psychedelics under the Cortexa brand; and Adaya which provides hybrid formulations and Australian-cultivated products. The company was formerly known as Cronos Australia Limited and changed its name to Vitura Health Limited in February 2023. Vitura Health Limited was incorporated in 2018 and is based in South Yarra, Australia.

Vitura Health Limited

Suite 8, Level 3, South Yarra, VIC, Australia, 3141

Key Executives

Name Title Year Born
Mr. Rodney Damon Cocks CEO & Executive Director NA
Mr. Thomas Godfrey Howitt ACIS, AICPA, B.Com., C.A, FTIA CFO & Company Secretary 1964
Mr. Guy Rothwell Headley Chief Commercial Officer & Executive Director NA
Mr. Ryan J. Tattle Chief Revenue Officer NA
Ms. Kirsty Garrett Chief Operating Officer NA
Mr. Jeffrey Lerner Head of Technology NA
Ms. Natalie Khoury Head of Customer Experience NA
Mr. Ben Cirillo Financial Controller NA
Mr. Rodney Damon Cocks CEO & Executive Director NA
Mr. Thomas Godfrey Howitt ACIS, AICPA, B.Com., C.A, FTIA CFO & Company Secretary 1964

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.